Real-time enrollment status for this extensive stage small cell lung cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:41 AM UTC
| NCT Number | NCT06598306 |
| Recruiting Status | Recruiting |
| Condition | Extensive Stage Small Cell Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 220 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Amgen |
| Last Updated on CT.gov | June 26, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT06598306 is currently recruiting participants. This clinical trial study for extensive stage small cell lung cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by Amgen. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06598306 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06598306 was last updated 2 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.